FR2581062B1 - Acides b-lactame hydroxamiques o-sulfates, a action therapeutique - Google Patents

Acides b-lactame hydroxamiques o-sulfates, a action therapeutique

Info

Publication number
FR2581062B1
FR2581062B1 FR8606108A FR8606108A FR2581062B1 FR 2581062 B1 FR2581062 B1 FR 2581062B1 FR 8606108 A FR8606108 A FR 8606108A FR 8606108 A FR8606108 A FR 8606108A FR 2581062 B1 FR2581062 B1 FR 2581062B1
Authority
FR
France
Prior art keywords
hydroxamic
sulphate
therapeutic action
lactam acids
lactam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8606108A
Other languages
English (en)
Other versions
FR2581062A1 (fr
Inventor
Joseph E Sundeen
William H Koster
Robert Zahler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of FR2581062A1 publication Critical patent/FR2581062A1/fr
Application granted granted Critical
Publication of FR2581062B1 publication Critical patent/FR2581062B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/12—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FR8606108A 1985-04-29 1986-04-28 Acides b-lactame hydroxamiques o-sulfates, a action therapeutique Expired - Fee Related FR2581062B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/728,432 US4638060A (en) 1985-04-29 1985-04-29 O-sulfated spiro β-lactam hydroxamic acids

Publications (2)

Publication Number Publication Date
FR2581062A1 FR2581062A1 (fr) 1986-10-31
FR2581062B1 true FR2581062B1 (fr) 1990-10-19

Family

ID=24926831

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8606108A Expired - Fee Related FR2581062B1 (fr) 1985-04-29 1986-04-28 Acides b-lactame hydroxamiques o-sulfates, a action therapeutique

Country Status (20)

Country Link
US (1) US4638060A (fr)
JP (1) JPS61257965A (fr)
AU (1) AU601944B2 (fr)
BE (1) BE904699A (fr)
CA (1) CA1273938A (fr)
CH (1) CH668073A5 (fr)
DE (1) DE3614317A1 (fr)
DK (1) DK190286A (fr)
ES (1) ES8800916A1 (fr)
FI (1) FI861693A (fr)
FR (1) FR2581062B1 (fr)
GB (1) GB2174392B (fr)
HU (1) HU194822B (fr)
IE (1) IE59630B1 (fr)
IT (1) IT1215652B (fr)
NL (1) NL8601051A (fr)
NZ (1) NZ215665A (fr)
PT (1) PT82467B (fr)
SE (1) SE8601963L (fr)
ZA (1) ZA862429B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143913A (en) * 1988-04-04 1992-09-01 E. R. Squibb & Sons, Inc. [3S(Z)]-3-[[(2-amino-4-thiazolyl)[[2-(hydroxyamino)-2-oxoethoxy]imino]acetyl]amino]-2,2-dimethyl-4-oxo-1-azetidinyl sulfate
UY34585A (es) 2012-01-24 2013-09-02 Aicuris Gmbh & Co Kg Compuestos b-lactámicos sustituidos con amidina, su preparación y uso
US20140275007A1 (en) * 2013-03-14 2014-09-18 Rempex Pharmaceuticals, Inc. Oxamazin antibiotics
CN113754651B (zh) * 2020-06-02 2023-04-18 中国医学科学院医药生物技术研究所 一种β-内酰胺化合物、其用途及其制备方法
CN113975396B (zh) * 2021-11-09 2022-11-29 中国医学科学院医药生物技术研究所 包含β-内酰胺类化合物的药物组合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260743A (en) * 1979-12-31 1981-04-07 Gist-Brocades N.V. Preparation of β-lactams and intermediates therefor
US4337197A (en) * 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates
JPS586589A (ja) 1981-07-01 1983-01-14 Hitachi Ltd 論理回路
JPS58113174A (ja) * 1981-12-26 1983-07-05 Toyama Chem Co Ltd 新規なアゼチジン誘導体またはその塩類を含有する抗菌剤
JPS58194856A (ja) 1982-05-10 1983-11-12 Yamanouchi Pharmaceut Co Ltd 新規２−アゼチジノン誘導体

Also Published As

Publication number Publication date
NZ215665A (en) 1988-11-29
IT8620227A0 (it) 1986-04-28
CA1273938C (fr) 1990-09-11
IT1215652B (it) 1990-02-22
ES8800916A1 (es) 1987-12-01
SE8601963L (sv) 1986-10-30
IE59630B1 (en) 1994-03-09
JPS61257965A (ja) 1986-11-15
IE861067L (en) 1986-10-29
CH668073A5 (fr) 1988-11-30
DK190286A (da) 1986-10-30
DE3614317A1 (de) 1986-11-06
ES554438A0 (es) 1987-12-01
DK190286D0 (da) 1986-04-24
AU601944B2 (en) 1990-09-27
FI861693A (fi) 1986-10-30
PT82467A (en) 1986-05-01
GB8609596D0 (en) 1986-05-21
NL8601051A (nl) 1986-11-17
AU5556886A (en) 1986-11-06
ZA862429B (en) 1986-11-26
PT82467B (pt) 1988-03-03
US4638060A (en) 1987-01-20
GB2174392B (en) 1988-11-09
HUT41384A (en) 1987-04-28
SE8601963D0 (sv) 1986-04-28
BE904699A (fr) 1986-08-18
HU194822B (en) 1988-03-28
FR2581062A1 (fr) 1986-10-31
GB2174392A (en) 1986-11-05
CA1273938A (fr) 1990-09-11
FI861693A0 (fi) 1986-04-22

Similar Documents

Publication Publication Date Title
FR2592048B1 (fr) Inhibiteurs d'ureido-renine, a action therapeutique
FR2599739B1 (fr) Acides biphenyl hydroxamiques a action therapeutique
KR880700730A (ko) 사출 구동장치
NO2000005I1 (no) Insulin aspart
FR2585252B1 (fr) Pousse-seringue
AT385664B (de) Elektromedizinisches therapiegeraet
DK175487D0 (da) Farmaceutisk aktive 2-thiomethyl-substitueret-1,4-dihydro-pyridiner
DE3675777D1 (de) Einspritzvorrichtung.
FR2590799B1 (fr) Seringue
FR2641191B2 (fr) Seringue a injection unique
AT383035B (de) Massagemaschine
FR2572725B1 (fr) Ethers bicycloheptane-substitues a action therapeutique
FR2583417B1 (fr) Acides 3-acylamino-2-oxo-1-azetidinesulfoniques a action therapeutique.
FR2581062B1 (fr) Acides b-lactame hydroxamiques o-sulfates, a action therapeutique
FR2580651B1 (fr) Analogues de thio-prostaglandines 7-oxabicycloheptane-substitues, a action therapeutique
FR2618777B1 (fr) Benzazepines a action therapeutique
FR2516924B1 (fr) Acides phosphinylalcanoyl- amines a action therapeutique
FR2558836B1 (fr) Analogues d'oxaprostaglandines a substituant 7-oxabicyloheptane, a action therapeutique
FR2578255B1 (fr) Acides 8-oxo-2-oxa-1-azabicyclo(4.2.0)octane-3-carboxyliques a action therapeutique
FR2533566B1 (fr) Imino- et amino-acides acyloxycetone-substitues a action therapeutique
FR2600332B1 (fr) P-aminophenols et derives a action therapeutique
FR2579204B1 (fr) Acylaminoalcanoyl urethanes ou thio-urethanes a action therapeutique
FR2602232B1 (fr) Acides n-nicotinoylamines
KR870000709U (ko) 로우터리식 약품투입기
DD261935A3 (de) Schaftmaschinenantrieb

Legal Events

Date Code Title Description
ST Notification of lapse